RAP1GDS1 Antikörper (Middle Region)
Kurzübersicht für RAP1GDS1 Antikörper (Middle Region) (ABIN929295)
Target
Alle RAP1GDS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- RAP1 GDS1 antibody was raised in rabbit using the middle region of RAP1 DS1 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
RAP1GDS1 Blocking Peptide, (ABIN940515), is also available for use as a blocking control in assays to test for specificity of this RAP1GDS1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RAP1GDS1 (RAP1, GTP-GDP Dissociation Stimulator 1 (RAP1GDS1))
-
Andere Bezeichnung
- RAP1GDS1
-
Hintergrund
- The smg GDP dissociation stimulator (smgGDS) protein is a stimulatory GDP/GTP exchange protein with GTPase activity. Synonyms: Polyclonal RAP1GDS1 antibody, Anti-RAP1GDS1 antibody, RAP1, GTP-GDP dissociation stimulator 1 antibody, GDS1 antibody, MGC118859 antibody, MGC118861 antibody, SmgGDS antibody.
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-